Inactive
Notice ID:36E79720R0010
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79720R0010 for an unrestrictive procurement for Human Insulins, for the Department of Veteran...
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79720R0010 for an unrestrictive procurement for Human Insulins, for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will make one award for each individual product group (group 1 and 2) or a combination of products groups to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC number. Solicitation # 36E79720R0010 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about January 3rd, 2020, with a tentative closing date of January 17th, 2020. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download on Contract Opportunities at the following URL: https://beta.sam.gov/search?index=opp. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Stevan Vasich. Questions can be e-mailed to: Stevan.Vasich@va.gov. The estimated annual requirements are as follows: Group 1 Line Item Description Package Size Total Estimated Annual Usage 1 Human R 10 ML Vial 401,899 2 Human N 10 ML Vial 797,954 3 Human 70/30 10 ML Vial 786,765 4 Short Acting/Intermediate Analog Mix Human (75/25 Mix or 70/30 Mix) 10 ML Vial 1632,521 5 Short Acting/Intermediate Analog Mix Human (75/25 Mix or 70/30 Mix) 5X3 ML Disposable Pen 235,244 Group 2 Line Item Description Package Size Total Estimated Annual Usage 1 Short Acting Analog Human 5X3 ML Disposable Pen 1,180,380 2 Short Acting Analog Human 10 ML Vial 1,287,581
